FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new chromone derivatives of general formula
,
wherein: R1 represents one or more identical or different substitutes on a benzene ring, each of which independently represents a hydrogen atom, or a halogen atom, or C1-4 alkoxy group, or OH group. or group -O(CH2)nO-, wherein n=1 or 2, R2 represents a hydrogen atom, or C1-4 alkyl group; A and B independently represent either a nitrogen atom, or a carbon atom; R3 represents a hydrogen atom or one or more identical or different substitutes specified in a group consisting of: a halogen atom, C1-4 alkyl group, C1-4 alkoxy group, group -O(CH2)nO-, wherein n=1 or 2, group NO2, group NHSO2R4, group NHR5, OH group, C1-4 halogenoalkyl group, CN group, or R3 makes a ring condensed with a benzene ring bearing it, specified in a group consisting of indole, benzimidazole, carbostyril, benzoxazolone and benzoxazolone and benzimidazolone, R4 represents C1-4 alkyl group, or C1-4 dialkylamino group, or C1-4 alkoxyalkyl group, or C1-4 dialkylaminoalkyl group, R5 represents a hydrogen atom, or C1-4 alkylcarbonyl group, or C1-4 alkoxycarbonyl group, and to its pharmaceutically acceptable salts, as well as to methods for preparing them, and to based pharmaceutical compositions, and to using them as a therapeutic agent for central nervous system disorders, as long as they possess the D3 dopaminergic ligand properties.
EFFECT: preparing the compositions for treating central nervous system disorders, as long as they possess the D3 dopaminergic ligand properties.
17 cl, 1 dwg, 2 tbl, 33 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL (POLY)AMINOALKYLAMINOALKYLAMIDE, ALKYL-UREA OR ALKYL-SULFONAMIDE DERIVATIVES OF EPIPODOPHYLLOTOXIN, METHOD OF OBTAINING THEREOF AND METHOD OF APPLICATION THEREOF IN THERAPY AS ANTI-CANCER MEDICATIONS | 2009 |
|
RU2529676C2 |
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
ARGINASE INHIBITORS AND THERAPEUTIC USE THEREOF | 2011 |
|
RU2586219C2 |
NOVEL CONDENSED DERIVATIVES OF IMIDAZOLE, INHIBITORS OF DIPEPTIDYL PEPTIDASE IV, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USING BASED ON THEREOF | 2003 |
|
RU2297418C9 |
COMBINATIVE MEDICINAL AGENT | 2003 |
|
RU2328280C2 |
DERIVATIVES OF NOSCAPINE (VARIANTS), COMBINATORY AND FOCUSED LIBRARIES, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PREPARING (VARIANTS) AND USING | 2006 |
|
RU2304584C1 |
INDOLYLMALEIMIDE DERIVATIVES, METHOD OF THEIR OBTAINING, THEIR APPLICATION AND PHARMACEUICAL COMPOSITION FOR TREATMENT OR PREVENTION OF T-LYMPHOCYTE AND/OR "ПКС"- MEDIATED DISORDERS OR DISEASES | 2003 |
|
RU2340610C2 |
DERIVATIVES OF 2-IMINOPYRROLIDINE | 2002 |
|
RU2270192C2 |
AZOLYL QUINOLINE AND QUINAZOLINE DERIVATIVES, PHARMASEUTICAL COMPOSITION CONTAINING THE SAME, USES THEREOF AND METHOD FOR TREATMENT OF DISEASES | 2002 |
|
RU2283841C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
Authors
Dates
2015-03-27—Published
2010-08-31—Filed